Page not found
Home print
Help us learn more about what it’s like to live with HPP.
> Click here to participate in a survey

Stay Informed

Receive the latest news and updates on hypophosphatasia.
I am a:
Privacy & Confidentiality Policy

News

Enobia Expands Clinical Program for ENB-0040, a Bone-targeted Enzyme Replacement Therapy for HypophosphatasiaNovember 02, 2009Enobia Announces Positive Clinical Results with ENB-0040, a Bone Targeted Enzyme Replacement Therapy for HypophosphatasiaSeptember 14, 2009All News go

The page you are looking for does not exist.

 

Homepage
Hypophosphatasia
- Key Discoveries in the History of HPP
- Clinical Presentation
- Diagnosis
- Pathophysiology
- Epidemiology
- Managing HPP
Science
- ENB-0040
- Fusion Protein
- Clinical Trials
- Nonclinical Studies
- Pipeline
- Glossary
Patients
- About Hypophosphatasia
- Disease Prevalence
- Causes of Hypophosphatasia
- Key Discoveries in Hypophosphatasia
- Treating Hypophosphatasia
- Therapies in Development for Hypophosphatasia
- How Can I Get Involved in a Clinical Trial for HPP?
- Additional Resources
Company
- Management Team
- Board of Directors
- Investors
News
- Press Releases
- Publications & Presentations
- Enobia in the news
Contact us
Privacy Policy
Sitemap